Association of Galectin-9 Soluble Immune Checkpoint with Clinical Prognostic Markers in Patients with Chronic Lymphocytic Leukemia

Aviwe Ntsethe, Phiwayinkosi Vusi Dludla, Bongani Brian Nkambule · 2025

Read Association of Galectin-9 Soluble Immune Checkpoint with Clinical Prognostic Markers in Patients with Chronic Lymphocytic Leukemia by Aviwe Ntsethe, Phiwayinkosi Vusi Dludla, Bongani Brian Nkambule (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12785695.txt.

Description

Aviwe Ntsethe, Phiwayinkosi Dludla, and Bongani Nkambule profiled soluble immune checkpoints in chronic lymphocytic leukemia blood, in a 2025 study. The disease swings widely between patients, and bead assays promise cheap monitoring if any marker truly tracks prognosis. The team measured six checkpoints, including galectin-9, plus a standard risk protein, and lined them up against staging, gene tests, and a composite index.

Five checkpoints ran far higher in patients than controls. Galectin-9 rose in step with the standard risk protein, the study's headline link. The authors propose it as a candidate prognostic marker for a disease that needs better ones. Validation in bigger cohorts comes next.

Catalog record

CREATORAviwe Ntsethe, Phiwayinkosi Vusi Dludla, Bongani Brian Nkambule
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE23 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12785695

Browse the full library · About the Tower of Babel